Clinical Trials Logo

Filter by:
  • Terminated  
  • Page [1]
NCT ID: NCT05279235 Terminated - Clinical trials for Moderate to Severe COVID-19

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Start date: March 14, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of JT001 (VV116) for the Treatment of Coronavirus Disease 2019 (COVID-19) in participants with moderate to severe COVID-19.